ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2026
Sheath-to-Artery Diameter Ratio: A Robust Predictor of Early Access-Site Adverse Events in Percutaneous Procedures.
Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVascular access site complications (VASCs) remain an important source of morbidity following percutaneous interventions. Although the sheath-to-femoral artery ratio is a recognized risk factor in transcatheter aortic valve implantation (TAVI), its role across a broader range of femoral procedures is less well defined.
objectiveTo evaluate the association between the sheath‑to‑artery diameter (SHAD) ratio and early VASCs in patients undergoing femoral percutaneous interventions with sheaths > 6 Fr.
methodsA nested case-control study was performed within a retrospective cohort of 2660 consecutive patients. A total of 177 patients who developed VASCs within 7 days were identified and compared with 353 propensity score-matched controls without complications. The propensity score included age, sex, body mass index, hypertension, diabetes mellitus, peripheral artery disease, and prior femoral access. The SHAD ratio was calculated using pre‑procedural computed tomography angiography (CTA). Inter‑observer agreement for arterial diameter was excellent (intraclass correlation coefficient 0.94). Receiver operating characteristic analysis identified the optimal cutoff (Youden index), and multivariable logistic regression with backward stepwise selection was internally validated by bootstrap. Anatomical factors (calcification, tortuosity) were examined as potential confounders.
resultsAfter matching, all baseline characteristics were well balanced (standardized differences < 0.10). The SHAD ratio was significantly higher in patients with VASCs than in controls (1.26 vs. 0.75; p < 0.001). A SHAD ratio ≥ 1.07 optimally predicted complications (AUC 0.83, 95% CI 0.80-0.87; sensitivity 82%; specificity 78%). In the final multivariable model, SHAD ≥ 1.07 remained the strongest independent predictor (OR 6.71, 95% CI 3.87-11.64; p < 0.001). Dual femoral access (OR 2.95, 95% CI 1.65-5.28) and procedural urgency (OR 1.98, 95% CI 1.18-3.32) also increased risk. Ultrasound‑guided puncture (OR 0.15, 95% CI 0.08-0.28) and fluoroscopy‑guided access (OR 0.14, 95% CI 0.07-0.26) were strongly protective. Anterior wall calcification was associated with a higher complication risk in univariable analysis but did not remain significant after adjustment for SHAD. Bootstrap internal validation yielded an optimism‑corrected AUC of 0.91 (95% CI 0.89-0.93), indicating good discrimination.
conclusionsA SHAD ratio ≥ 1.07 is a robust predictor of early VASCs across multiple large‑bore femoral interventions. Maintaining a sheath‑to‑artery relationship ≤ 1.0, together with image‑guided access, may substantially reduce complications. The incorporation of SHAD assessment into pre‑procedural planning is supported, pending external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.